Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Suggestive association between OPRM1 and impulse control disorders in Parkinson's disease
Florence Cormier‐Dequaire, Samir Bekadar, Mathieu Anheim, et al.
Movement Disorders (2018) Vol. 33, Iss. 12, pp. 1878-1886
Closed Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Initiation of pharmacological therapy in Parkinson's disease: when, why, and how
Rob M.A. de Bie, Carl E Clarke, Alberto J. Espay, et al.
The Lancet Neurology (2020) Vol. 19, Iss. 5, pp. 452-461
Closed Access | Times Cited: 156
The Neuropsychiatry of Parkinson Disease: A Perfect Storm
Daniel Weintraub, Eugenia Mamikonyan
American Journal of Geriatric Psychiatry (2019) Vol. 27, Iss. 9, pp. 998-1018
Open Access | Times Cited: 130
Impulse Control Disorders in Parkinson's Disease. A Brief and Comprehensive Review
Emilia Gatto, Victoria Aldinio
Frontiers in Neurology (2019) Vol. 10
Open Access | Times Cited: 96
Apathy in Parkinson’s Disease: Clinical Patterns and Neurobiological Basis
Matthieu Béreau, Vincent Van Waes, Mathieu Servant, et al.
Cells (2023) Vol. 12, Iss. 12, pp. 1599-1599
Open Access | Times Cited: 23
Genetic prediction of impulse control disorders in Parkinson's disease
Daniel Weintraub, Marijan Posavi, Pierre Fontanillas, et al.
Annals of Clinical and Translational Neurology (2022) Vol. 9, Iss. 7, pp. 936-949
Open Access | Times Cited: 28
Impact of Subthalamic Deep Brain Stimulation on Impulse Control Disorders in Parkinson's Disease: A Prospective Study
Marie des Neiges Santin, Paul Voulleminot, Agathe Vrillon, et al.
Movement Disorders (2020) Vol. 36, Iss. 3, pp. 750-757
Closed Access | Times Cited: 42
Impulse Control Disorders in Parkinson's Disease: Epidemiology, Pathogenesis and Therapeutic Strategies
Junfang Zhang, Xixi Wang, Ya Feng, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 35
Impulse control disorders in Parkinson’s disease: What’s new?
Ana Marqués, Simon J.G. Lewis
Journal of Neurology (2025) Vol. 272, Iss. 2
Closed Access
Management of psychiatric disorders in Parkinson’s disease
Daniel Weintraub
Neurotherapeutics (2020) Vol. 17, Iss. 4, pp. 1511-1524
Open Access | Times Cited: 32
Motivational and cognitive predictors of apathy after subthalamic nucleus stimulation in Parkinson’s disease
Matthieu Béreau, Astrid Kibleur, Mathieu Servant, et al.
Brain (2023) Vol. 147, Iss. 2, pp. 472-485
Closed Access | Times Cited: 12
Multimodal neuroimaging fusion unravel structural-functional-neurotransmitter change in Parkinson's disease with impulse control disorders
Caiting Gan, Xingyue Cao, Huimin Sun, et al.
Neurobiology of Disease (2024) Vol. 198, pp. 106560-106560
Open Access | Times Cited: 3
Endogenous Opiates and Behavior: 2018
Richard J. Bodnar
Peptides (2020) Vol. 132, pp. 170348-170348
Closed Access | Times Cited: 21
Impulse control disorders and related behaviors in Parkinson's disease: risk factors, clinical and genetic aspects, and management
Johann Faouzi, Jean‐Christophe Corvol, Louise‐Laure Mariani
Current Opinion in Neurology (2021) Vol. 34, Iss. 4, pp. 547-555
Open Access | Times Cited: 19
Prognosis of impulse control disorders in Parkinson’s disease: a prospective controlled study
Thomas Wirth, Thibaut Goetsch, Jean‐Christophe Corvol, et al.
Journal of Neurology (2024) Vol. 271, Iss. 5, pp. 2412-2422
Closed Access | Times Cited: 2
Association of Rare Genetic Variants in Opioid Receptors with Tourette Syndrome.
Christel Depienne, Sorana Ciura, Oriane Trouillard, et al.
DOAJ (DOAJ: Directory of Open Access Journals) (2019) Vol. 9
Open Access | Times Cited: 21
Increased large-scale inter-network connectivity in relation to impulsivity in Parkinson’s disease
Jinsoo Koh, Yoshiki Kaneoke, Tomohiro Donishi, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 19
Impulse Control Disorders in Parkinson’s Disease: From Bench to Bedside
Andrea Augustine, Catharine A. Winstanley, Vaishnav Krishnan
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 17
Parkinson's disease polygenic risk score is not associated with impulse control disorders: A longitudinal study
Jonas Ihle, F. Artaud, Samir Bekadar, et al.
Parkinsonism & Related Disorders (2020) Vol. 75, pp. 30-33
Open Access | Times Cited: 17
Naltrexone Use in Treating Hypersexuality Induced by Dopamine Replacement Therapy: Impact of OPRM1 A/G Polymorphism on Its Effectiveness
Audrey Verholleman, Caroline Victorri‐Vigneau, Edouard‐Jules Laforgue, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 8, pp. 3002-3002
Open Access | Times Cited: 14
Non-motor symptom burden in patients with Parkinson’s disease with impulse control disorders and compulsive behaviours: results from the COPPADIS cohort
Silvia Jesús, Miguel A. Labrador‐Espinosa, A. D. Adarmes, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 14
Dopamine genetic risk score predicts impulse control behaviors in Parkinson’s disease
Alison Hall, Samuel R. Weaver, Lindsey J. Compton, et al.
Clinical Parkinsonism & Related Disorders (2021) Vol. 5, pp. 100113-100113
Open Access | Times Cited: 12
Predicting impulse control disorder in Parkinson's Disease: Is there a formula?
Francesc Valldeoriola, Viviana I. Torres
European Neuropsychopharmacology (2023) Vol. 72, pp. 4-5
Open Access | Times Cited: 4
Impulse control disorder: Review on clinical, pharmacologic, and genetic risk factors
Vincent Leclercq, Jean‐Christophe Corvol
Revue Neurologique (2024) Vol. 180, Iss. 10, pp. 1071-1077
Closed Access | Times Cited: 1
Pharmacogenomics—a New Frontier for Individualized Treatment of Parkinson’s Disease
Jia-Si Liu, Ying Chen, Dandan Shi, et al.
Current Neuropharmacology (2022) Vol. 21, Iss. 3, pp. 536-546
Open Access | Times Cited: 7
A Systematic Review of Parkinson’s Disease Pharmacogenomics: Is There Time for Translation into the Clinics?
Vladimira Vuletić, Valentino Rački, Eliša Papić, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 13, pp. 7213-7213
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top